Shockwave Therapy 
in Gladstone at ECHO

ESWT for Plantar Fasciitis, Tendinopathy, Chronic Pain & Tissue Recovery

Shockwave therapy is one of the more compelling additions to musculoskeletal care in recent decades — a non-invasive, evidence-based intervention that works at the tissue level to stimulate healing in structures that are often slow to respond to other treatment. Despite the name, it has nothing to do with electrical shock or shock therapy — the "shockwave" refers to acoustic pressure waves, similar in principle to ultrasound, delivered through a handheld applicator against the skin. There is no electricity transferred, no needles, and no anesthesia required. Most people find it tolerable and some find it surprisingly unremarkable for how effective it is. It's particularly well-suited for chronic tendon and soft tissue conditions where circulation is poor, the healing response has stalled, or the problem has persisted despite other approaches.

​

How shockwave therapy works

​

Radial shockwave therapy delivers high-energy acoustic pressure waves into the tissue through a handheld applicator. These waves create a mechanical stimulus — a process called mechanotransduction — that triggers a cascade of biological responses in the treated tissue in ways that are both similar to and different from acupuncture:

• Increased local circulation — pressure waves stimulate blood flow into areas of chronic restriction, including tendons and fascia that are inherently poorly vascularized

• Fibroblast activation and collagen remodeling — shockwave stimulates the fibroblasts responsible for tendon and connective tissue repair, initiating genuine structural healing rather than just symptom suppression

• Pain modulation — acoustic waves influence local pain signaling through neurological mechanisms, reducing both local and referred pain

• Breakdown of calcific deposits — in calcific tendinopathies, shockwave can mechanically disrupt and facilitate resorption of calcium deposits

The result is a treatment that doesn't just reduce pain — it addresses the underlying tissue pathology that's causing it. This mirrors one of the foundational principles of East Asian Medicine: treating the root rather than the branch. Symptom suppression without addressing what's generating the symptom tends to produce temporary relief at best. Shockwave, like EAM, works toward resolution by changing the underlying conditions — in this case, restoring the tissue's structural integrity and healing capacity rather than simply dampening its output. This is one of the reasons shockwave therapy produces more durable results than many symptom-focused interventions for chronic tendon conditions.

​​​

Mechanisms of action — for practitioners and the scientifically curious

​

The therapeutic effects of radial shockwave therapy are produced through a cascade of molecular and physiological responses initiated by the acoustic pressure wave. The following mechanisms are supported by the peer-reviewed literature:
 

Molecular mechanisms

• Reactive hypervascularization — shockwave stimulates angiogenic signaling pathways, promoting the formation of new blood vessels in poorly vascularized tissue. This is one of the primary mechanisms by which shockwave restores healing capacity in chronically degenerated tendons and fascia.

• Growth factor release — the mechanical stimulus triggers release of multiple growth factors including VEGF, TGF-β1, and NO, initiating downstream cell proliferation and tissue repair cascades

• Increased collagen synthesis — fibroblast stimulation through mechanotransduction upregulates collagen production, supporting structural remodeling of degenerated connective tissue

• Cell proliferation and reduced proteolysis — shockwave promotes cell division while simultaneously reducing the enzymatic breakdown of extracellular matrix components, shifting the tissue environment toward net repair

• Disintegration and resorption of calcification — acoustic pressure mechanically disrupts calcific deposits and promotes their resorption, with documented effects in calcific tendinopathy of the shoulder and plantar fascia

(Chen et al., JOR 2004; Hsu et al., JOR 2004; Hausdorf et al., Neurosci 2008; Han et al., Foot Ankle Int 2009; Vetrano et al., Knee Surg Sports Traum Arth 2011)

​

Physiological effects

• Positive regulation of inflammation — shockwave induces a controlled, inflammatory-mediated healing process rather than suppressing inflammation. This is a clinically significant distinction: the goal is to restart a stalled healing response, not dampen an active one. Tissue that has become chronically degenerated has often lost the acute inflammatory signaling needed to initiate repair — shockwave restores it.

• Fibroblast and osteoblast stimulation — direct stimulation of connective tissue and bone-forming cells supports both soft tissue repair and bone healing at entheses and apophyses

• Neo-angiogenesis — new vessel formation improves nutrient delivery and metabolic exchange in tissue that has become avascular or hypovascular

• Cell metabolism stimulation — shockwave upregulates cellular metabolic activity, supporting the energy-dependent processes of tissue repair and remodeling

• Stimulus to proliferation and collagen synthesis — reinforcing the molecular effects above at the tissue level, producing measurable structural changes over a consistent course of treatment

(d'Agostino et al., 2015)

​

Shockwave therapy through an East Asian Medicine lens

​

East Asian Medicine has always understood healing as a process of moving what has become stuck — restoring the circulation of energy and blood to tissue that has become cold, contracted, stagnant, or poorly nourished. Chronic tendinopathy, fibrotic scar tissue, calcific deposits, and poorly vascularized connective tissue are, in EAM terms, classic presentations of blood stasis and qi stagnation in the local channels — tissue that has lost its vitality because what should be moving through it has slowed or stopped. Restoring the function of the tissues and restoring the flow of the channels are not separate goals — they are the same goal approached from different directions. The channels inform the tissue, and the tissue is where the channel lives — dysfunction in one inevitably affects the other. When the tissue degenerates or becomes fibrotic, it blocks the channel that runs through it. When the channel is obstructed, the tissue it nourishes will eventually reflect that obstruction. Shockwave addresses the tissue directly — removing the structural obstacle that is blocking circulation — and in doing so, creates the conditions for the channel to resume what it was always meant to do.

Acupuncture addresses this through multiple understood mechanisms — among them, inserting a needle at a precise location to create a controlled microtrauma that provokes a local healing response, stimulates circulation, and activates the body's own regulatory mechanisms. The needle is not doing the healing. It is creating a signal that the body responds to. One of those signaling pathways is mechanotransduction — the conversion of a mechanical stimulus into a biological response — and it is this particular mechanism that shockwave therapy shares.

Shockwave delivers a mechanical stimulus through a different medium — acoustic pressure waves rather than a needle — but the mechanotransductive logic is the same: create a controlled stimulus at a specific site, provoke the body's own healing response, restore circulation and tissue vitality to an area that has lost it. The difference is one of intensity and depth of mechanical effect. Where the mechanotransductive effect of a needle creates a precise, focal stimulus, shockwave creates a broader and more forceful pressure wave that penetrates deeper into fibrotic and degenerated tissue — tissue that may no longer respond adequately to needle-based stimulation alone.

From a channel perspective, shockwave can be understood as working along the same tissue planes and fascial pathways that classical needling has defined through an interconnected network of acupuncture point locations and meridians. Research on thermal transport along meridian pathways — showing that stimulation at one point produces temperature and circulatory changes at distal sites along the same channel — suggests that the channels are, at least in part, interdependent on fascial and connective tissue structures. Shockwave, applied along these same planes, works within the same anatomical substrate that classical EAM has been addressing for centuries.

​

This framing matters for practitioners for a specific reason: shockwave therapy is not a departure from EAM principles. It is an amplification of them — a modernized tool that does what acupuncture has always done, with greater mechanical force, in tissue that has moved beyond what needle-based stimulation alone can adequately reach. Integrating it into an EAM practice is not a departure from the defining philosophy of the medicine — it is a recognition that EAM and modern physiology are describing the same body, the same tissue, and the same healing processes through different languages. The names differ. The reality they point to does not. Shockwave therapy, understood through an EAM lens, is simply another way of restoring what has stagnated — using a tool that reaches where needles alone sometimes cannot.

​

What shockwave therapy treats

​

Shockwave therapy has its strongest evidence base in chronic musculoskeletal conditions — particularly those involving tendons, fascia, and soft tissue that have become degenerative, fibrotic, or slow to heal:

• Plantar fasciitis and heel pain — one of the most extensively studied applications, with multiple systematic reviews and meta-analyses confirming meaningful pain reduction and functional improvement

• Achilles tendinopathy — both mid-portion and insertional presentations respond well to shockwave, particularly when combined with loading protocols

• Rotator cuff tendinopathy and frozen shoulder — including calcific and non-calcific rotator cuff presentations and adhesive capsulitis; 2024–2025 research confirms significant improvement in pain and range of motion

• Lateral epicondylitis (tennis elbow) — strong evidence for pain reduction and functional recovery in chronic presentations

• Patellar tendinopathy — particularly for chronic presentations unresponsive to conservative management

• Gluteal tendinopathy and hip pain — an underrecognized application with growing evidence

• Morton's neuroma — emerging evidence for a condition frequently resistant to conservative treatment; shockwave offers a non-invasive alternative before surgical intervention

• Trigger points and myofascial pain — shockwave applied to active trigger points disrupts the contraction knot and reduces referred pain patterns

• Chronic muscle tension and overuse injuries — including IT band syndrome, shin splints, and repetitive strain presentations

Shockwave therapy for tendinopathy and chronic musculoskeletal pain — what the research shows

​

The evidence base for shockwave therapy in musculoskeletal conditions is substantial and continues to grow.

​

A 2025 systematic review and meta-analysis comparing ESWT to low-level laser therapy across 12 studies found ESWT produced superior outcomes for pain relief, functional improvement, and long-term results in tendinopathies and plantar fasciitis.

​

A 2024 systematic review and meta-analysis published in BMC Sports Science, Medicine and Rehabilitation found ESWT significantly reduced pain across multiple tendinopathy presentations — including Achilles, patellar, and rotator cuff tendinopathies — with results durable at follow-up.

​

A 2025 randomized controlled trial found that ESWT significantly improved tendon healing and pain reduction by enhancing collagen remodeling and reducing inflammation — supporting its use not just for symptom relief but for genuine structural recovery.

​

For plantar fasciitis specifically, a 2025 meta-analysis published in Foot & Ankle Surgery found ESWT produced comparable results to other leading treatment modalities across 15 randomized controlled trials involving 1,123 patients.

​

The honest picture: shockwave therapy works best for chronic presentations — conditions that have been present long enough that the tissue has stopped healing on its own. For acute injuries, other approaches are often more appropriate.

​

How acupuncture and shockwave therapy work together — and when to use each

​

Acupuncture and shockwave therapy work through similar, but distinct, mechanisms and address different aspects of dysfunction. Understanding the distinction helps clarify when one is more appropriate than the other — and when combining them makes the most clinical sense.

Acupuncture works through multiple overlapping mechanisms — nervous system regulation, pain modulation, improved local and systemic circulation, hormonal signaling, immune modulation, and direct tissue effects at the needle site. It is both a local and systemic tool, and it excels at conditions where the pattern is complex, where multiple systems are involved, or where improved circulation and nervous system regulation are what the tissue needs to recover. For most musculoskeletal presentations, acupuncture is an excellent primary intervention.

Shockwave therapy works through acoustic pressure waves that stimulate fibroblast activity, initiate collagen remodeling, improve local circulation, and break down tissue that has become chronically degenerated or fibrotic. At its core, this is a frequency-based intervention — the therapeutic effect is produced not by a chemical or pharmacological agent but by a specific pattern of mechanical energy delivered to tissue. East Asian Medicine has long understood that the body responds to mechanical, vibrational, and energetic inputs — from the oscillating stimulus of a retained needle, to the penetrating thermodynamic and energetic effects of moxa, to the rhythmic pressure of cupping and massage, to the precisely calibrated electrical frequency of electroacupuncture. Shockwave operates through a different medium and at a different intensity, but the underlying principle — that a precisely delivered energetic stimulus initiates a healing response both locally and at locations further downstream from the input, with effects that extend beyond the treatment site to influence broader physiological function and overall health — is at the core of EAM philosophy. It is most appropriate in two specific scenarios:

​

• Repetitive use and overuse injuries — where the tissue is being strained faster than it can recover, and standard acupuncture treatment cannot fully keep ahead of the ongoing demand. Tendons under chronic repetitive stress develop degenerative changes — not just inflammation — that require a more mechanically direct stimulus to restart the healing cascade. Shockwave provides that stimulus in a way that acupuncture alone often can't.

• Advanced tissue degeneration — where the tendon, fascia, or connective tissue has deteriorated to the point where its own healing response is significantly impaired. This includes presentations dominated by fibrotic or scarred tissue — where the normal tissue architecture has been replaced by dense, poorly vascularized connective tissue that resists the circulatory and regulatory effects of acupuncture alone.

The relationship between acupuncture and shockwave therapy is best understood as a clinical triage decision rather than a fixed protocol. Acupuncture remains the primary tool for most musculoskeletal presentations at ECHO — working through circulation, nervous system regulation, and the body's own healing mechanisms to produce change over a consistent course of care. Shockwave enters the picture when that approach has reached its limits: when tissue degeneration has advanced beyond what improved circulation and regulatory support can adequately address, when repetitive loading is outpacing the body's capacity to recover, or when fibrosis and structural changes have become the primary obstacle standing between the patient and meaningful improvement. In those cases, shockwave doesn't replace acupuncture — it addresses the specific dimension of the problem that is at the root of an obstacle to cure. Some patients will benefit from one, some from the other, and some from both — the clinical picture determines which.

​

Why we added shockwave at ECHO

​

One of the foundational concepts in East Asian Medicine — and one that resonates across many systems of clinical practice — is that obstacles to cure exist: factors that limit the body's capacity to respond to treatment. Structural tissue degeneration, fibrosis, and calcification are among the most significant of these obstacles in musculoskeletal presentations. They don't yield to regulation or circulation alone. Shockwave therapy was added to ECHO specifically because it addresses this category of obstacle directly — removing the structural barrier that has been limiting what acupuncture can achieve, and in doing so, creating the conditions for EAM to work more fully once that barrier is resolved. In some cases shockwave is the right first intervention. In others it picks up where acupuncture has reached its limit. Either way, the goal is the same: getting the body to a place where its own capacity to heal can actually do its job.

​​

Contraindications and precautions

​

Shockwave therapy is contraindicated and will not be performed if any of the following apply:

• Active cancer or malignancy

• Blood clotting disorders or current use of anticoagulant medications

• Open wounds, skin infection, active rash, or skin discoloration at the treatment site

• Acute fracture, acute injury, or active inflammation and swelling at the treatment site

• Current confirmed tendon rupture or tear

• Allodynia, hyperalgesia, or significantly impaired or absent sensation at the treatment site

• Pregnancy

• An implanted pacemaker or spinal cord stimulator

• Known DVT or thrombosis in the treatment area

• Corticosteroid injection at the treatment site within the past 12 weeks

• Patients under 18 years of age — shockwave therapy is generally not performed on skeletally immature patients due to the risk of growth plate injury. An exception may be considered for Osgood-Schlatter disease, where emerging evidence supports low-energy shockwave applied away from the growth plate. Please discuss with Dr. Ev before scheduling.

If you have severe osteoporosis, peripheral neuropathy, or an active inflammatory arthritis flare, please discuss this with Dr. Ev before scheduling — treatment may be appropriate with modifications or physician sign off.

​

What to expect

​

Shockwave therapy sessions are typically 10–15 minutes for the treatment itself. The sensation during treatment is distinct — most people describe it as a deep, repetitive pressure that can range from mildly uncomfortable to more intense depending on the area being treated and the pressure settings used. Treatment is always calibrated to your tolerance and adjusted throughout the session.

​

Post-treatment soreness in the treated area is common for 24–48 hours — this is a normal and expected part of the tissue response and typically settles within a day or two.

​

Most shockwave protocols involve 3–6 sessions spaced one week apart. Chronic and long-standing conditions may require a longer course. Most people begin to notice meaningful change within the first 2–3 sessions.

​

Is shockwave therapy covered by insurance?

​

Shockwave therapy is available as a self-pay service and is not billed to insurance. It can be booked as a standalone session or added to any acupuncture appointment — use the dropdown arrow when scheduling to add it on. FSA and HSA funds are eligible for shockwave therapy sessions.

​

Schedule a shockwave therapy session »
View shockwave therapy packages »
Learn more about pain care at ECHO »